Success message is not being displayed for certain drug set submissions

[KMJ1618]

I'm attempting to submit the drug set entry below; when I click the Submit button using either Chrome or Firefox browsers, the fields of the submission form show a green outline, but no success message is being displayed. This is in contrast to numerous successful submissions that I had made earlier today.

I suspect that this issue might be due to this paper having an unusually long URL (319 characters); unfortunately, an alternative, shorter URL for this paper doesn't seem to be available. I could create and submit a tiny URL for each excessively long URL, but I would instead recommend trying to correct this problem with the input form, as other users likely won't do this for their long URLs.

Drug Set Name: 7 drugs for COVID-19 repurposing against SARS-CoV-2 protease enzyme from Parikesit & Nurdiansyah via docking

Drug Set URL: https://www.researchgate.net/profile/Arli_Aditya_Parikesit/publication/340502629_Drug_Repurposing_Option_for_COVID-19_with_Structural_Bioinformatics_of_Chemical_Interactions_Approach/links/5e8d81e092851c2f52887c08/Drug-Repurposing-Option-for-COVID-19-with-Structural-Bioinformatics-of-Chemical-Interactions-Approach.pdf

How is this set related to COVID-19 research? Docking analysis was used to evaluate 7 drugs for COVID-19 repurposing, against SARS-CoV-2 protease enzyme. Tables 1, 2 and 3 of Parikesit & Nurdiansyah (2020) Drug Repurposing Option for COVID-19 with Structural Bioinformatics of Chemical Interactions Approach. Cermin Dunia Kedokteran, 47 (3), pp.222-226.

Drug Set: Chloroquine Phosphate Lopinavir Oseltamivir Peramivir Remdesivir Ribavirin Zanamivir

[KMJ1618]

Another attempted submission that does not display a success message, again with a long URL (256 characters):

Drug Set Name: 19 drugs against spike protein (S-protein) of SARS-CoV-2 interacting with human ACE2 receptor from Smith via docking

Drug Set URL: https://chemrxiv.org/articles/Repurposing_Therapeutics_for_the_Wuhan_Coronavirus_nCov-2019_Supercomputer-Based_Docking_to_the_Viral_S_Protein_and_Human_ACE2_Interface/11871402/4?utm_campaign=Nabla%20Newsletter&utm_medium=email&utm_source=Revue%20newsletter

How is this set related to COVID-19 research? Docking was used to identify 19 drugs against spike protein (S-protein) of SARS-CoV-2 interacting with the human ACE2 receptor. Table 3 from Smith (2020) Repurposing therapeutics for covid-19: Supercomputer-based docking to the sars-cov-2 viral spike protein and viral spike protein-human ace2 interface. ChemRxiv

Drug Set: pemirolast benserazide luteolin-monoarabinoside pyruvic acid calcium isoniazid quercetol quercitin protirelin carbazochrome nitrofurantoin benserazide carbazochrome sapropterin Vidarabine eriodictyol tazobactum phenformin hcl carbazochrome vildagliptin demethyl-coclaurine

[KMJ1618]

Update: I subsequently successfully submitted the drug set below, which has a much shorter URL, and a success message was displayed; this supports my suspicion that it is the length of the URLs above causing this problem. I also successfully submitted (with success messages displayed) several additional drug sets beyond the one below, each with a brief URL.

Drug Set Name: 4 drugs against SARS-CoV main protease from Li et al. via high-throughput screening

Drug Set URL: https://www.biorxiv.org/content/10.1101/2020.01.28.922922v2

How is this set related to COVID-19 research? High-throughput screening was used to identify 4 small-molecule drugs against SARS-CoV main protease. Li et al. (2020) Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening. BioRxiv

Drug Set: 4 drugs Prulifloxacin Bictegravir Nelfinavir Tegobuvir

[KMJ1618]

Since the decision was made at today's lab meeting that this issue won't be programmatically resolved, one suggestion is to at least display an error message when the user attempts to submit an excessively long URL -- currently, all of the boxes in the drug set submission form turn green upon such an unsuccessful attempt, which seems to incorrectly indicate successful submission, so at least alerting the user that their URL is too long, and that they should generate a tiny URL for it, would be helpful...